Inspire IVF PCL (BKK:IVF)
0.6300
-0.0100 (-1.56%)
At close: Jun 12, 2026
Inspire IVF PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 58.66 | 61.87 | 105.7 | 121.55 | 63.31 | 11.24 |
Other Revenue | 7.22 | 7.99 | 2.64 | 0.55 | 1.52 | 0.64 |
| 65.88 | 69.87 | 108.34 | 122.09 | 64.84 | 11.88 | |
Revenue Growth (YoY) | -37.93% | -35.51% | -11.26% | 88.31% | 445.76% | -31.81% |
Cost of Revenue | 42.63 | 42.92 | 44.06 | 42.04 | 32.27 | 13.7 |
Gross Profit | 23.25 | 26.95 | 64.28 | 80.06 | 32.57 | -1.82 |
Selling, General & Admin | 46.75 | 44.25 | 35.43 | 24.46 | 17.67 | 4.4 |
Operating Expenses | 46.75 | 44.25 | 35.43 | 24.46 | 17.67 | 4.4 |
Operating Income | -23.5 | -17.3 | 28.85 | 55.6 | 14.89 | -6.22 |
Interest Expense | -4.32 | -4.39 | -4.67 | -4.48 | -2.31 | -0.02 |
Pretax Income | -27.83 | -21.69 | 24.18 | 51.12 | 12.58 | -6.24 |
Income Tax Expense | -6.22 | -4.32 | 2.03 | 10.13 | 2.52 | - |
Earnings From Continuing Operations | -21.6 | -17.37 | 22.15 | 40.98 | 10.06 | -6.24 |
Minority Interest in Earnings | 0 | 0 | - | - | - | - |
Net Income | -21.6 | -17.37 | 22.15 | 40.98 | 10.06 | -6.24 |
Net Income to Common | -21.6 | -17.37 | 22.15 | 40.98 | 10.06 | -6.24 |
Net Income Growth | - | - | -45.95% | 307.34% | - | - |
Shares Outstanding (Basic) | 440 | 440 | 320 | 216 | 180 | 180 |
Shares Outstanding (Diluted) | 440 | 440 | 320 | 216 | 180 | 180 |
Shares Change (YoY) | 24.84% | 37.52% | 48.35% | 19.82% | - | - |
EPS (Basic) | -0.05 | -0.04 | 0.07 | 0.19 | 0.06 | -0.03 |
EPS (Diluted) | -0.05 | -0.04 | 0.07 | 0.19 | 0.06 | -0.03 |
EPS Growth | - | - | -63.57% | 239.97% | - | - |
Free Cash Flow | -16.29 | -14.39 | 19.86 | 55.8 | 29.54 | - |
Free Cash Flow Per Share | -0.04 | -0.03 | 0.06 | 0.26 | 0.16 | - |
Dividend Per Share | - | - | 0.024 | 0.065 | - | - |
Dividend Growth | - | - | -63.08% | - | - | - |
Gross Margin | 35.29% | 38.57% | 59.33% | 65.57% | 50.23% | -15.34% |
Operating Margin | -35.67% | -24.76% | 26.63% | 45.53% | 22.97% | -52.33% |
Profit Margin | -32.79% | -24.86% | 20.45% | 33.57% | 15.52% | -52.49% |
Free Cash Flow Margin | -24.73% | -20.59% | 18.33% | 45.70% | 45.56% | - |
EBITDA | -16.04 | -9.85 | 35.44 | 60.19 | 19.51 | 0.08 |
EBITDA Margin | -24.35% | -14.10% | 32.71% | 49.30% | 30.08% | 0.68% |
D&A For EBITDA | 7.46 | 7.45 | 6.59 | 4.6 | 4.61 | 6.3 |
EBIT | -23.5 | -17.3 | 28.85 | 55.6 | 14.89 | -6.22 |
EBIT Margin | -35.67% | -24.76% | 26.63% | 45.53% | 22.97% | -52.33% |
Effective Tax Rate | - | - | 8.40% | 19.82% | 20.03% | - |
Revenue as Reported | 65.88 | 69.87 | 108.34 | 122.09 | 64.84 | 11.88 |
Advertising Expenses | - | - | - | - | 0.14 | - |